Back to Search Start Over

Renin-angiotensin-aldosterone system inhibitors and COVID-19.

Authors :
Quinn KL
Fralick M
Zipursky JS
Stall NM
Source :
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [CMAJ] 2020 May 19; Vol. 192 (20), pp. E553-E554. Date of Electronic Publication: 2020 Apr 24.
Publication Year :
2020

Abstract

Competing Interests: Competing interests: None declared.

Subjects

Subjects :
COVID-19
Humans
Pandemics
Angiotensin II Type 2 Receptor Blockers therapeutic use
Angiotensin-Converting Enzyme Inhibitors therapeutic use
Coronavirus Infections complications
Diabetes Complications complications
Diabetes Mellitus drug therapy
Hypertension complications
Hypertension drug therapy
Pneumonia, Viral complications
Renin-Angiotensin System drug effects

Details

Language :
English
ISSN :
1488-2329
Volume :
192
Issue :
20
Database :
MEDLINE
Journal :
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Publication Type :
Academic Journal
Accession number :
32332039
Full Text :
https://doi.org/10.1503/cmaj.200619
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details